Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pete Holm who wrote (685)	5/3/1997 9:12:00 PM
From: Lee Warzala	of 6136

Mr. Harmon pointed out to me the 2.2 multiplier for inventory versus sales. Then Agouron went to market with $105 million in salable inventory. Coming from the pharmaceutical industry, at least my company tries to keep a five month supply. This translates into Agouron projecting that they will do $360 million in sales. Any explanation why this number is much higher than yours?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next